Breaking News

AstraZeneca Gets $1B from U.S. to Deliver COVID-19 Vax by Fall

Aims to make potential COVID-19 vaccine AZD1222 widely accessible with first deliveries in September 2020

By: Contract Pharma

Contract Pharma Staff

AstraZeneca received support of more than $1 billion from the U.S. BARDA for the development, production and delivery of a potential COVID-19  vaccine, starting in the fall. The development program includes a Phase III clinical trial with 30,000 participants and a pediatric trial. AstraZeneca is collaborating with several countries and organizations to make University of Oxford Jenner Institute’s potential COVID-19 vaccine widely accessible around the world. The vaccine contains the genetic m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters